Cancer drug developer CG Oncology valued at $1.75B in strong IPO debut

Reuters

related news
Cancer drugmaker ArriVent follows on CG’s heels with $175M IPO

Yahoo! Finance

1月 26日, 2024
Cancer drug developer CG Oncology valued at $1.75B in strong IPO debut

Reuters

1月 25日, 2024

Get In Touch

Contact Us